Silicon BioDevices Inc.
Lab-on-a-chip for rapid heart attack detection
This article was originally published in Start Up
Executive Summary
Silicon BioDevices Inc. is looking to save critical time in heart attack diagnosis as well as billions of dollars in health care costs with the first lab-quality, reader-free, POC device for high-sensitivity measurement of cardiac troponin, a key marker of cardiac damage. Using one drop of whole blood, the company's self-contained blood test provides results within 15 minutes to determine whether or not a patient has experienced a heart attack.